KATHERINE MILLER: Open Payments
NPI 1154185015 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 37 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $521 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Dexcom, Inc. | 1 | $43 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
| PFIZER INC. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $32 |
Products named: Wegovy, Veozah, MOUNJARO, Dexcom G6 Transmitter, Ozempic, QULIPTA, JARDIANCE, ACCRUFER.
Industry payments across GA — which companies pay providers there.
